Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Plos Medicine|July 6, 2019
Clinical, microbiologic, and immunologic determinants of mortality in hospitalized patients with HIV-associated tuberculosis: A prospective cohort studyCharlotte Schutz, David Barr, Bruno B Andrade, et al.Frontiers in Immunology|April 8, 2021
Functional and Activation Profiles of Mucosal-Associated Invariant T Cells in Patients With Tuberculosis and HIV in a High Endemic SettingAvuyonke Balfour, Charlotte Schutz, Rene Goliath, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2017
Mortality in Severe Human Immunodeficiency Virus-Tuberculosis Associates With Innate Immune Activation and Dysfunction of MonocytesSaskia Janssen, Charlotte Schutz, Amy Ward, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2020
"SILVAMP TB LAM" Rapid Urine Tuberculosis Test Predicts Mortality in Patients Hospitalized With Human Immunodeficiency Virus in South AfricaBianca Sossen, Tobias Broger, Andrew D Kerkhoff, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 15, 2026
Microglia-independent rAAV-induced inflammation causes persistent ocular immune dysregulation rescued by S1P receptor modulationPhilip M Langer, Alison J Clare, Xudong Peng, et al.The Lancet. Infectious Diseases|June 4, 2019
Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy studyTobias Broger, Bianca Sossen, Elloise du Toit, et al.Ebiomedicine|March 24, 2022
Serial measurement of M. tuberculosis in blood from critically-ill patients with HIV-associated tuberculosisDavid A Barr, Charlotte Schutz, Avuyonke Balfour, et al.Trials|January 14, 2024
CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancerHisham Mehanna, Piers Gaunt, Anthony Kong, et al.Sexually Transmitted Infections|December 25, 2025
High prevalence and incidence of curable sexually transmitted infections among young women using oral HIV pre-exposure prophylaxis in sub-Saharan Africa: results from the INSIGHT Cohort studyIrene Mukui, Sue Peacock, Deborah Donnell, et al.Journal of the International AIDS Society|February 16, 2025
Preferences for HIV pre-exposure prophylaxis formulations and delivery among young African women: results of a discrete choice experimentWendy W Dlamini, Brenda G Mirembe, Meighan L Krows, et al.Pageof 5